Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

Journal of Hypertension

Volumn 29, Issue 10, 2011, Pages 1980-1987

  Tomii, Yasuhiro ^a   Toyoda, Kazunori ^a   Nakashima, Takahiro ^a   Nezu, Tomohisa ^a   Koga, Masatoshi ^a   Yokota, Chiaki ^a   Nagatsuka, Kazuyuki ^a   Minematsu, Kazuo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Blood pressure; Heart rate; Hypertension; Outcome; Stroke; Thrombolysis; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; NICARDIPINE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE PRESSURE; STROKE; SYSTOLIC BLOOD PRESSURE; VOMITING; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; MALE; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84855995716     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834a764e     Document Type: Article

References (28)

1. The NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al., ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
3. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al., SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-282. (Pubitemid 46138121)
4. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679-1685. (Pubitemid 34298612)
5. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, et al., Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008;39:3316-3322.
6. Tsivgoulis G, Frey JL, Flaster M, Sharma VK, Lao AY, Hoover SL, et al. Pretissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Stroke 2009;40:3631-3634.
7. Yong M, Diener HC, Kaste M, Mau J. Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke 2005;36:2619-2625.
8. Yong M, Kaste M. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial. Stroke 2008;39:366-372. (Pubitemid 351619457)
9. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, et al., The SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009;40:2442-2449.
10. Adams HP Jr, Del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al., American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711. (Pubitemid 46691097)
11. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35:520-526.
12. Toyoda K, Okada Y, Fujimoto S, Hagiwara N, Nakachi K, Kitazono T, et al. Blood pressure changes during the initial week after different subtypes of ischemic stroke. Stroke 2006;37:2637-2639. (Pubitemid 44454691)
13. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 h of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006;37:1810-1815. (Pubitemid 44297734)
14. Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, et al., for Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register. Stroke 2009;40:3591-3595.
15. Shinohara Y, Yamaguchi T. Outline of the Japanese Guidelines for the Management of Stroke 2004 and subsequent revision. Int J Stroke 2008;3:55-62. (Pubitemid 351228146)
16. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41. (Pubitemid 23014379)
18. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al., on behalf of the collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992.
19. Barber PA, Demchuk AM, Zhang J, Buchan AM, for the ASPECTS Study Group. Validity and reliability of a semiquantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670-1674. (Pubitemid 30248478)
20. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The strokethrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke 2006;37:2957-2962. (Pubitemid 44900816)
21. Delgado-Mederos R, Ribo M, Rovira A, Rubiera M, Munuera J, Santamarina E, et al. Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology 2008;71:552-558.
22. Mattle HP, Kappeler L, Arnold M, Fischer U, Nedeltchev K, Remonda L, et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005;36:264-268. (Pubitemid 40170805)
23. Toyoda K, Fujimoto S, Kamouchi M, Iida M, Okada Y. Acute blood pressure levels and neurological deterioration in different subtypes of ischemic stroke. Stroke 2009;40:2585-2588.
24. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905.
25. Bath PM; for the VISTA Collaboration. Relationship between hyperacute blood pressure and outcome after ischemic stroke. Stroke 2009;40:2098-2103.
26. Tikhonoff V, Zhang H, Richart T, Staessen JA. Blood pressure as a prognostic factor after acute stroke. Lancet Neurol 2009;8:938-948.
27. Wilcox R, Bousser MG, Betteridge DJ, Schernthaner G, Pirags V, Kupfer S, Dormandy J, PROactive Investigators. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglit Azone Clinical Trial In macro Vascular Events 04). Stroke 2007;38:865-873. (Pubitemid 46568445)
28. American Diabetes Association. Summary of revisions for the 2009 Clinical Practice Recommendations. Diabetes Care 2009;32(Suppl 1):S3-S5.